3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1
3
Phase EARLY_PHASE1
2
Phase 4
1
Phase 3
1
Status
Recruiting
2
Completed
2
Withdrawn
1
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Metformin
3
Letrozole
3
Sperm Injections, Intracytoplasmic
2
Progesterone
2
Lidocaine
2
Indocyanine Green
2
Gentamicins
2
Estradiol
2
Clomiphene
2
Bevacizumab
2
Acitretin
2
tirbanibulin
1
technetium Tc 99m nanocolloid
1
suvorexant
1
pomalidomide
1
pembrolizumab
1
pasireotide
1
nilotinib
1
methylnaltrexone
1
ledipasvir
1
ixazomib
1
gadolinium ethoxybenzyl DTPA
1
gadofosveset trisodium
1
exemestane
1
encorafenib
1
dolutegravir
1
ceftolozane, tazobactam drug combination
1
binimetinib
1
bicalutamide
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Withdrawn
×
abemaciclib
×
Clear all
NCT03988114
2019-09-06
proMONARCH
Eli Lilly and Company
Phase 4
Withdrawn